Compound 56 (Figure 30) resulted to be the most active to inhibit VEGFR kinase (IC50 = 3.8 nM) and proliferation of HUEVEC cancer cells (IC50 = 5.5 nM); the docking analysis confirmed that this compound is suitable bonded to VEGFR-2 [133]. This evidence concerns the gene KDR and cancer.